224 related articles for article (PubMed ID: 22592322)
1. Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy.
Watarai H; Yamada D; Fujii S; Taniguchi M; Koseki H
Int J Hematol; 2012 Jun; 95(6):624-31. PubMed ID: 22592322
[TBL] [Abstract][Full Text] [Related]
2. Efficient Production of Functional Human NKT Cells from Induced Pluripotent Stem Cells - Reprogramming of Human Vα24
Yamada D; Iyoda T; Shimizu K; Sato Y; Koseki H; Fujii SI
Bio Protoc; 2017 May; 7(10):e2277. PubMed ID: 34541057
[TBL] [Abstract][Full Text] [Related]
3. Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy.
Aoki T; Motohashi S; Koseki H
Inflamm Regen; 2023 May; 43(1):27. PubMed ID: 37170375
[TBL] [Abstract][Full Text] [Related]
4. Efficient Regeneration of Human Vα24
Yamada D; Iyoda T; Vizcardo R; Shimizu K; Sato Y; Endo TA; Kitahara G; Okoshi M; Kobayashi M; Sakurai M; Ohara O; Taniguchi M; Koseki H; Fujii SI
Stem Cells; 2016 Dec; 34(12):2852-2860. PubMed ID: 27422351
[TBL] [Abstract][Full Text] [Related]
5. Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer.
Takami M; Ihara F; Motohashi S
Front Immunol; 2018; 9():2021. PubMed ID: 30245690
[TBL] [Abstract][Full Text] [Related]
6. Novel in vitro invariant natural killer T cell functional assays.
Balasko A; Graydon C; Fowke KR
J Immunol Methods; 2021 Dec; 499():113171. PubMed ID: 34706265
[TBL] [Abstract][Full Text] [Related]
7. Roles of NKT cells in cancer immunotherapy.
Bae EA; Seo H; Kim IK; Jeon I; Kang CY
Arch Pharm Res; 2019 Jul; 42(7):543-548. PubMed ID: 30859410
[TBL] [Abstract][Full Text] [Related]
8. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
Front Immunol; 2018; 9():1266. PubMed ID: 29928278
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-15 enhances the expansion and function of natural killer T cells from adult peripheral and umbilical cord blood.
Lin SJ; Huang YC; Cheng PJ; Lee PT; Hsiao HS; Kuo ML
Cytokine; 2015 Dec; 76(2):348-355. PubMed ID: 26481260
[TBL] [Abstract][Full Text] [Related]
10. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.
Tagawa T; Wu L; Anraku M; Yun Z; Rey-McIntyre K; de Perrot M
J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885
[TBL] [Abstract][Full Text] [Related]
11. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
Guan P; Schaub R; Nichols KE; Das R
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
[TBL] [Abstract][Full Text] [Related]
12. α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials.
Zhang Y; Springfield R; Chen S; Li X; Feng X; Moshirian R; Yang R; Yuan W
Front Immunol; 2019; 10():1126. PubMed ID: 31244823
[TBL] [Abstract][Full Text] [Related]
13. Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells.
Kitayama S; Zhang R; Liu TY; Ueda N; Iriguchi S; Yasui Y; Kawai Y; Tatsumi M; Hirai N; Mizoro Y; Iwama T; Watanabe A; Nakanishi M; Kuzushima K; Uemura Y; Kaneko S
Stem Cell Reports; 2016 Feb; 6(2):213-27. PubMed ID: 26862702
[TBL] [Abstract][Full Text] [Related]
14. Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy.
Wang Y; Sedimbi SK; Löfbom L; Besra GS; Porcelli SA; Cardell SL
Front Immunol; 2019; 10():352. PubMed ID: 30881361
[TBL] [Abstract][Full Text] [Related]
15. NKT cells as an ideal anti-tumor immunotherapeutic.
Fujii S; Shimizu K; Okamoto Y; Kunii N; Nakayama T; Motohashi S; Taniguchi M
Front Immunol; 2013 Dec; 4():409. PubMed ID: 24348476
[TBL] [Abstract][Full Text] [Related]
16. Characterizing porcine invariant natural killer T cells: A comparative study with NK cells and T cells.
Yang G; Artiaga BL; Lewis ST; Driver JP
Dev Comp Immunol; 2017 Nov; 76():343-351. PubMed ID: 28694168
[TBL] [Abstract][Full Text] [Related]
17. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
18. New Genetically Manipulated Mice Provide Insights Into the Development and Physiological Functions of Invariant Natural Killer T Cells.
Ren Y; Sekine-Kondo E; Tateyama M; Kasetthat T; Wongratanacheewin S; Watarai H
Front Immunol; 2018; 9():1294. PubMed ID: 29963043
[TBL] [Abstract][Full Text] [Related]
19. The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy.
Taniguchi M; Tashiro T; Dashtsoodol N; Hongo N; Watarai H
Int Immunol; 2010 Jan; 22(1):1-6. PubMed ID: 19858073
[TBL] [Abstract][Full Text] [Related]
20. Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response.
Zeng J; Wang S
Stem Cells Transl Med; 2014 Jan; 3(1):69-80. PubMed ID: 24292792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
